Acura Pharmaceuticals, Inc. financial statements
Acura Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2021
| Revenue | USD 1.56M | EODHD |
| Net income | −USD 879K | EODHD |
| Cash and equivalents | USD 65K | EODHD |
Acura Pharmaceuticals, Inc. financials on 6ix · Acura Pharmaceuticals, Inc. on 6ix